Vinflunine News
Vinflunine currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Vinflunine with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Javlor is indicated in monotherapy for the treatment of adult patients with advanced or metastatic transitional-cell carcinoma of the urothelial tract after failure of a prior platinum-containing...
- Evidence level: L5
- Predicted indications (20):
- amyotrophic lateral sclerosis (99.0%)
- bilateral parasagittal parieto-occipital polymicrogyria (98.7%)
- Mills syndrome (98.7%)
- amyotrohpic lateral sclerosis type 22 (98.6%)
- amyotrophic lateral sclerosis, susceptibility to (98.6%)
- axial spondylometaphyseal dysplasia (98.6%)
- lower motor neuron syndrome with late-adult onset (98.5%)
- autosomal dominant mitochondrial myopathy with exercise intolerance (98.4%)
- monomelic amyotrophy (98.4%)
- trichomegaly-retina pigmentary degeneration-dwarfism syndrome (98.2%)
- lethal arthrogryposis-anterior horn cell disease syndrome (98.1%)
- kidney pelvis sarcomatoid transitional cell carcinoma (95.6%)
- prostatic urethra urothelial carcinoma (95.5%)
- infiltrating bladder urothelial carcinoma sarcomatoid variant (95.4%)
- renal pelvis papillary urothelial carcinoma (95.4%)
- transitional cell carcinoma (93.7%)
- immunodeficiency without anhidrotic ectodermal dysplasia (91.0%)
- SMARCA4-deficient sarcoma of thorax (91.0%)
- liposarcoma (90.9%)
- ovarian myxoid liposarcoma (90.4%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.